Behavioral	behavioral	O	O	O	O
effects	effects	O	O	O	O
of	of	O	O	O	O
urotensin-II	urotensin-ii	O	O	O	O
centrally	centrally	O	O	O	O
administered	administered	O	O	O	O
in	in	O	O	O	O
mice	mice	O	O	O	O
.	.	O	O	O	O

Urotensin-II	urotensin-ii	O	O	O	O
(	(	O	O	O	O
U-II	u-ii	O	O	O	O
)	)	O	O	O	O
receptors	receptors	O	O	O	O
are	are	O	O	O	O
widely	widely	O	O	O	O
distributed	distributed	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
central	central	O	O	O	O
nervous	nervous	O	O	O	O
system	system	O	O	O	O
.	.	O	O	O	O

Intracerebroventricular	intracerebroventricular	O	O	O	O
(	(	O	O	O	O
i.c.v	i.c.v	O	O	O	O
.	.	O	O	O	O
)	)	O	O	O	O
injection	injection	O	O	O	O
of	of	O	O	O	O
U-II	u-ii	O	O	O	O
causes	causes	O	O	O	O
hypertension	hypertension	O	DISEASE	OTHERS	I
and	and	O	O	O	O
bradycardia	bradycardia	O	DISEASE	OTHERS	I
and	and	O	O	O	O
stimulates	stimulates	O	O	O	O
prolactin	prolactin	O	O	O	O
and	and	O	O	O	O
thyrotropin	thyrotropin	O	O	OTHERS	I
secretion	secretion	O	O	O	O
.	.	O	O	O	O

However	however	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
behavioral	behavioral	O	O	O	O
effects	effects	O	O	O	O
of	of	O	O	O	O
centrally	centrally	O	O	O	O
administered	administered	O	O	O	O
U-II	u-ii	O	O	O	O
have	have	O	O	O	O
received	received	O	O	O	O
little	little	O	O	O	O
attention	attention	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
the	the	O	O	O	O
present	present	O	O	O	O
study	study	O	O	O	O
,	,	O	O	O	O
we	we	O	O	O	O
tested	tested	O	O	O	O
the	the	O	O	O	O
effects	effects	O	O	O	O
of	of	O	O	O	O
i.c.v	i.c.v	O	O	O	O
.	.	O	O	O	O

injections	injections	O	O	O	O
of	of	O	O	O	O
U-II	u-ii	O	O	O	O
on	on	O	O	O	O
behavioral	behavioral	O	O	O	O
,	,	O	O	O	O
metabolic	metabolic	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
endocrine	endocrine	O	O	O	O
responses	responses	O	O	O	O
in	in	O	O	O	O
mice	mice	O	O	O	O
.	.	O	O	O	O

Administration	administration	O	O	O	O
of	of	O	O	O	O
graded	graded	O	O	O	O
doses	doses	O	O	O	O
of	of	O	O	O	O
U-II	u-ii	O	O	O	O
(	(	O	O	O	O
1	1	O	O	O	O
-	-	O	O	O	O
10,000	10,000	O	O	O	O
ng/mouse	ng/mouse	O	O	O	O
)	)	O	O	O	O
provoked	provoked	O	O	O	O
:	:	O	O	O	O
(	(	O	O	O	O
1	1	O	O	O	O
)	)	O	O	O	O
a	a	O	O	O	O
dose-dependent	dose-dependent	O	O	O	O
reduction	reduction	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
number	number	O	O	O	O
of	of	O	O	O	O
head	head	O	O	O	O
dips	dips	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
hole-board	hole-board	O	O	O	O
test	test	O	O	O	O
;	;	O	O	O	O
(	(	O	O	O	O
2	2	O	O	O	O
)	)	O	O	O	O
a	a	O	O	O	O
dose-dependent	dose-dependent	O	O	O	O
reduction	reduction	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
number	number	O	O	O	O
of	of	O	O	O	O
entries	entries	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
white	white	O	O	O	O
chamber	chamber	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
black-and-white	black-and-white	O	O	O	O
compartment	compartment	O	O	O	O
test	test	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
number	number	O	O	O	O
of	of	O	O	O	O
entries	entries	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
central	central	O	O	O	O
platform	platform	O	O	O	O
and	and	O	O	O	O
open	open	O	O	O	O
arms	arms	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
plus-maze	plus-maze	O	O	O	O
test	test	O	O	O	O
;	;	O	O	O	O
and	and	O	O	O	O
(	(	O	O	O	O
3	3	O	O	O	O
)	)	O	O	O	O
a	a	O	O	O	O
dose-dependent	dose-dependent	O	O	O	O
increase	increase	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
duration	duration	O	O	O	O
of	of	O	O	O	O
immobility	immobility	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
forced-swimming	forced-swimming	O	O	O	O
test	test	O	O	O	O
and	and	O	O	O	O
tail	tail	O	O	O	O
suspension	suspension	O	O	O	O
test	test	O	O	O	O
.	.	O	O	O	O

Intracerebroventricular	intracerebroventricular	O	O	O	O
injection	injection	O	O	O	O
of	of	O	O	O	O
U-II	u-ii	O	O	O	O
also	also	O	O	O	O
caused	caused	O	O	O	O
an	an	O	O	O	O
increase	increase	O	O	O	O
in	in	O	O	O	O
:	:	O	O	O	O
food	food	O	O	O	O
intake	intake	O	O	O	O
at	at	O	O	O	O
doses	doses	O	O	O	O
of	of	O	O	O	O
100	100	O	O	O	O
and	and	O	O	O	O
1,000	1,000	O	O	O	O
ng/mouse	ng/mouse	O	O	O	O
,	,	O	O	O	O
water	water	O	O	O	O
intake	intake	O	O	O	O
at	at	O	O	O	O
doses	doses	O	O	O	O
of	of	O	O	O	O
100	100	O	O	O	O
-	-	O	O	O	O
10,000	10,000	O	O	O	O
ng/mouse	ng/mouse	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
horizontal	horizontal	O	O	O	O
locomotion	locomotion	O	O	O	O
activity	activity	O	O	O	O
at	at	O	O	O	O
a	a	O	O	O	O
dose	dose	O	O	O	O
of	of	O	O	O	O
10,000	10,000	O	O	O	O
ng/mouse	ng/mouse	O	O	O	O
.	.	O	O	O	O

Whatever	whatever	O	O	O	O
was	was	O	O	O	O
the	the	O	O	O	O
dose	dose	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
central	central	O	O	O	O
administration	administration	O	O	O	O
of	of	O	O	O	O
U-II	u-ii	O	O	O	O
had	had	O	O	O	O
no	no	O	O	O	O
effect	effect	O	O	O	O
on	on	O	O	O	O
body	body	O	O	O	O
temperature	temperature	O	O	O	O
,	,	O	O	O	O
nociception	nociception	O	O	O	O
,	,	O	O	O	O
apomorphine-induced	apomorphine-induced	O	O	O	O
penile	penile	O	O	OTHERS	I
erection	erection	O	O	OTHERS	I
and	and	O	O	O	O
climbing	climbing	O	O	O	O
behavior	behavior	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
stress-induced	stress-induced	O	O	O	O
plasma	plasma	O	O	O	O
corticosterone	corticosterone	CHEMICALS	O	OTHERS	I
level	level	O	O	O	O
.	.	O	O	O	O

Taken	taken	O	O	O	O
together	together	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
present	present	O	O	O	O
study	study	O	O	O	O
demonstrates	demonstrates	O	O	O	O
that	that	O	O	O	O
the	the	O	O	O	O
central	central	O	O	O	O
injection	injection	O	O	O	O
of	of	O	O	O	O
U-II	u-ii	O	O	O	O
at	at	O	O	O	O
doses	doses	O	O	O	O
of	of	O	O	O	O
1	1	O	O	O	O
-	-	O	O	O	O
10,000	10,000	O	O	O	O
ng/mouse	ng/mouse	O	O	O	O
induces	induces	O	O	O	O
anxiogenic-	anxiogenic-	O	O	O	O
and	and	O	O	O	O
depressant-like	depressant-like	O	O	O	O
effects	effects	O	O	O	O
in	in	O	O	O	O
mouse	mouse	O	O	O	O
.	.	O	O	O	O

These	these	O	O	O	O
data	data	O	O	O	O
suggest	suggest	O	O	O	O
that	that	O	O	O	O
U-II	u-ii	O	O	O	O
may	may	O	O	O	O
be	be	O	O	O	O
involved	involved	O	O	O	O
in	in	O	O	O	O
some	some	O	O	O	O
aspects	aspects	O	O	O	O
of	of	O	O	O	O
psychiatric	psychiatric	O	DISEASE	OTHERS	I
disorders	disorders	O	O	OTHERS	I
.	.	O	O	O	O

